Aurora Cannabis (ACB) Convertible Debt (2018 - 2023)
Aurora Cannabis (ACB) posted quarterly Convertible Debt of $5.1 million for Q4 2023, down 93.89% year-on-year from $83.6 million in Q4 2022, and down 75.87% on a QoQ basis from $21.2 million in Q3 2023.
Aurora Cannabis (ACB) Convertible Debt (2018 - 2023) Analysis & Trends
Aurora Cannabis (ACB) has reported Convertible Debt for 6 consecutive years, with $5.1 million the latest figure, recorded in Q4 2023.
- Quarterly Convertible Debt fell 93.89% year-over-year to $5.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $5.1 million (down 93.89% YoY) and the FY2023 annual result came in at $48.5 million, down 69.28% from the prior year.
- Convertible Debt declined to $5.1 million in Q4 2023 per ACB's latest filing, from $21.2 million in the prior quarter.
- Over the last five years, Convertible Debt for ACB reached as high as $246.3 million in Q4 2021 and fell as low as $5.1 million in Q4 2023.
- A 5-year average of $172.6 million and a median of $209.0 million in 2020 frame the typical range for Convertible Debt.
- Annual changes were most pronounced in 2019 — Convertible Debt jumped 34.75% — and 2023, when it sank 93.89%.
- Year by year, Convertible Debt stood at $205.4 million in 2019, then grew by 7.84% to $221.5 million in 2020, then rose by 11.2% to $246.3 million in 2021, then plunged by 66.04% to $83.6 million in 2022, then slumped by 93.89% to $5.1 million in 2023.
- According to Business Quant data, Convertible Debt over the past three periods registered $5.1 million, $21.2 million, and $48.5 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5.11 Mn |
| Sep 30, 2023 | 21.19 Mn |
| Jun 30, 2023 | 48.47 Mn |
| Mar 31, 2023 | 98.06 Mn |
| Dec 31, 2022 | 83.64 Mn |
| Sep 30, 2022 | 163.92 Mn |
| Jun 30, 2022 | 156.59 Mn |
| Mar 31, 2022 | 233.57 Mn |
| Dec 31, 2021 | 246.27 Mn |
| Sep 30, 2021 | 240.13 Mn |
| Jun 30, 2021 | 238.51 Mn |
| Mar 31, 2021 | 226.06 Mn |
| Dec 31, 2020 | 221.47 Mn |
| Sep 30, 2020 | 217.05 Mn |
| Jun 30, 2020 | 212.70 Mn |
| Mar 31, 2020 | 218.41 Mn |
| Dec 31, 2019 | 205.37 Mn |
| Sep 30, 2019 | 200.62 Mn |
| Jun 30, 2019 | 200.06 Mn |
| Mar 31, 2019 | 214.85 Mn |